Affiliation:
1. UNIVERSITY OF HEALTH SCIENCES, İSTANBUL ŞİŞLİ HAMİDİYE ETFAL HEALTH RESEARCH CENTER, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, THE DEPARTMENT OF UROLOGY
Abstract
Objective: This study was designed to observe how the depressive state due to human papilloma virus
infection affects sexual functions in sexually active men.
Material and Methods: Between 2020-2022, 77 primary male patients who applied to the XXX Hospital
and diagnosed with genital warts (GW) by physical examination were included in the study. The patients
were divided into two groups according to the number and the size of the warts (small size vs. larger size).
The patients were asked to fill out the Hospital Anxiety Depression (HAD) scale and International Index of
Erectile Function (IIEF-5) forms. The data of the two groups were compared and analyzed.
Results: The mean age was 39.7±10.3, BMI kg/m2 27.0±7.2. Patients divided into 2 groups in terms of wart
sizes showed normal distribution. The HAD scale part was found to be abnormal in 13% of patients in small
wart size group and 52.5% of 21 patients in larger wart size group (p<0.0001). According to the evaluation
of the IIEF-5 scale, it was observed that 13.5% of 5 patients in small size group and 47.5% of 19 patients in
larger size group had severe sexual functions (p<0.0001). No significant difference was observed between
the 2 groups with chronic diseases (p=0.263).
Conclusion: Anxiety and depression appear and become evident in patients diagnosed with GWs from
the moment of diagnosis. It may be necessary to examine this issue carefully and to involve psychiatry
consultations in the management when necessary.
Reference20 articles.
1. 1- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 9. Lyon (FR): International Agency for Research on Cancer, 1996.
2. 2-Taheri R, Bayatani N, Razavi M, Mirmohammadkhani M. Risk factors for genital wart in men. Koomesh J. 2017;19(2):320–6. http://koomeshjournal.semums.ac.ir/article-1-3285-en.html
3. 3-Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;13(1):39. https://doi.org/10.1186/1471-2334-13-39
4. 4-Canvin M, Sinka K, Hughes G, Mesher D. Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis. Sexually transmitted infections. 2017;93(2):125-8. https://doi.org/10.1136/sextrans-2016-052626
5. 5-Akcali S, Goker A, Ecemis T, Kandiloglu AR, Sanlidag T. Human papilloma virus frequency and genotype distribution in a Turkish population. Asian Pac J Cancer Prev. 2013;14(1):503–506. https://doi.org/10.7314/apjcp.2013.14.1.503